While oil and its refined derivatives are still the mainstay of our energy economy, their prices are rising – in fact, high prices for gasoline and diesel are major drivers of the current high rates of inflation, and are partly responsible for the strong push to promote electric vehicles (EVs). But switching to EVs doesn’t end our reliance on energy. It will just make us trade one issue – reliance on oil – for another – reliance on lithium batteries. In this case, as Elon Musk has said, “Lithium
Tesla is sending out invites to its highly anticipated Investor Day on March 1st, but CEO Elon Musk says there will be more to come — his Master Plan part 3.
Annaly (NLY) delivered earnings and revenue surprises of 3.49% and 61.06%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
V.F., an S&P 500 Dividend Aristocrat, raised its payout for at least 25 straight years before cutting. Here's how to select dividend stocks for safety.
Digital Turbine (APPS) delivered earnings and revenue surprises of -21.62% and 12.24%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
Bill Gates looks for income, too. This is how he gets it.
After the markets closed on Tuesday, VistaGen Therapeutics Inc (NASDAQ: VTGN) reported a Q3 FY23 net loss of $(9.8) million or $(0.05) per share, narrower than the consensus of $(0.07). William Blair estimated an EPS loss of $(0.06). VistaGen says that it is not advisable to resume the PALISADE-2 study after failed Phase 3 PALISADE-1 trial of PH94B for the acute treatment of social anxiety disorder (SAD). Also Read: Vistagen Strengthens Its Neurology-Focused Pipeline With Pherin Pharma Acquisiti
Traders took heart that Fed Chair Jerome Powell, when he wasn’t being questioned by David Rubinstein on how he gets by on $190,000 per year, didn’t commit on Tuesday to having to be even more aggressive on interest rates given the huge 517,000 surge in nonfarm payrolls. Powell said rates would have to go even higher than the market currently expects “if we continue to get” strong labor market or higher inflation reports. Economists at Morgan Stanley point out that the January number reflects three factors it believes to be temporary: unusually warm weather, the resolution of California higher-education strikes and a very strong seasonal adjustment boost.
The headline numbers for Lincoln National (LNC) give insight into how the company performed in the quarter ended December 2022, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
“This time is different,” Burry tweeted Tuesday, including a chart that showed the roughly 40% stock market drop—and multiple bear market rallies—that occurred during the dotcom bubble.
Shares of Google parent Alphabet are down in Wall Street trading after a glitch in the company’s new artificial intelligence (AI) platform, Bard, contributed inaccurate information in promotional video.
The days of $100 oil may not be over.
Despite the Fed raising rates multiple times over the past year, most financial institutions are still paying a paltry amount on their savings accounts. Factors like your age, marital status and career all play a part in exactly how much emergency savings you need.
Disney CEO Bob Iger delivered some magic.
Credit Suisse has suffered its biggest annual loss since the 2008 financial crisis and scrapped bonuses for its top executives as the scandal-hit lender embarks on a drastic overhaul.
Plug Power (PLUG) closed at $15.90 in the latest trading session, marking a -1.49% move from the prior day.
Artificial intelligence marvel ChatGPT can write poetry, answer trivia questions and take tests. But it falls flat with S&P 500 stock picks — meaning you'll need to look elsewhere.
PepsiCo posted a nearly 11% rise in sales for the fourth quarter as higher prices for its beverages and snacks continued to offset rising costs. The beverage maker said Thursday that it expects continued growth this year, with organic revenue, which strips out the effects of foreign-currency fluctuations, acquisitions and divestitures, projected to rise 6%. Chief Executive Ramon Laguarta said the company expects inflationary pressures to persist throughout the year.
The company said it expected adjusted profit in the range of $10.70 to $11.10 per share for the full year, compared with analysts' average estimate of $11.65, according to Refinitiv IBES data. AbbVie's weak forecast suggests that Humira rivals could nibble away at the blockbuster drug's market share at a faster pace this year than analysts' projections.Amgen Inc recently launched Amjevita, the first such competition for Humira in the U.S., at a 5% and 55% discount to the drug's monthly price of $6,922.